Pulmonary Neoplasia
Pulmonary neoplasia is the area within pulmonology concerned with tumors arising in the lung, dominated by primary lung carcinoma. It is the leading cause of cancer death worldwide, and clinical practice divides it into two broad lineages with very different biology and management: non-small cell lung cancer and small cell lung cancer.
Definition
Pulmonary neoplasia denotes abnormal new tissue growth originating in the lung, most importantly malignant epithelial tumors (lung carcinomas), which are classified by histology and increasingly by molecular profile into non-small cell and small cell types.
Scope
This area orients the reader to the major categories of lung tumors, the histologic and molecular split that organizes the field, and the cross-cutting tasks of screening and TNM staging. It links to the detailed topics rather than duplicating them, and treats neoplasia as a reference subject within respiratory medicine rather than as clinical guidance.
Sub-topics
Key concepts
- Non-small cell vs small cell histologic dichotomy
- Adenocarcinoma, squamous cell, and large cell subtypes
- Tobacco smoke as the dominant risk factor
- Driver mutations and targetable oncogenes
- TNM staging (IASLC/UICC)
- Low-dose CT screening of high-risk populations
- Distinction of primary lung tumors from metastases
Mechanisms
Most lung carcinomas arise from the bronchial or alveolar epithelium through accumulated genetic and epigenetic damage, classically driven by carcinogens in tobacco smoke. The histologic split between non-small cell and small cell carcinoma reflects different cells of origin and growth behavior, and within non-small cell disease specific driver alterations define molecular subsets. Staging by the TNM system summarizes tumor size and local extent, nodal involvement, and distant spread, which together determine prognosis and the broad treatment category.
Clinical relevance
Because lung neoplasia is common and lethal, recognizing how it is categorized, staged, and detected underpins much of thoracic oncology and informs evidence appraisal across pulmonology. This entry describes how the disease is classified and studied; it is not a basis for individual diagnostic or treatment decisions.
Epidemiology
Lung cancer is the most frequently diagnosed cancer and the leading cause of cancer mortality globally, with tobacco smoking the predominant risk factor; non-small cell histologies account for the large majority of cases and small cell carcinoma for a smaller, smoking-associated minority.
History
The clinical separation of lung cancer into small cell and non-small cell types emerged from twentieth-century pathology and the observation that the two behave differently and respond differently to therapy. The IASLC staging project has since periodically revised the TNM groupings on the basis of large international databases, refining how the disease is described and prognosticated.
Related topics
Seminal works
- thai-2021
- goldstraw-2016
- sung-2021
Frequently asked questions
- Why is lung cancer split into non-small cell and small cell types?
- The two lineages differ in cell of origin, growth rate, and response to therapy, so the histologic distinction has long organized both classification and the broad approach to management.
- Is pulmonary neoplasia always cancer?
- No. The term covers new tissue growth in the lung, which can be benign or malignant, but the area is dominated clinically by malignant primary lung carcinoma, and metastases from other organs are also common lung tumors.